Feinstein Institutes awarded $2.9 million NIH funding for polygenic embryo selection studies
Genetic testing and selection of embryos generated from in vitro fertilization (IVF) have given rise to the controversial “designer baby” debate. Recently, the use of a new technology called polygenic embryo selection (PES) has developed to identify the risk for complex diseases of adulthood. To further study the accuracy – and the ethics – of PES, researchers at The Feinstein Institutes for Medical Research have been awarded a $2.9 million grant from the National Institutes of Health s (NIH) National Human Genome Research Institute (NHGRI).
Image Credit: Feinstein Institutes for Medical Research
For decades, reproductive geneticists have been able to identify rare, serious genetic disorders like Down syndrome or cystic fibrosis prior to implantation of embryos in women undergoing IVF. But through PES, geneticists aim to evaluate embryos for more common diseases that may (or may no
NIH researchers find many people want secondary genomic findings after initially refusing
nih.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nih.gov Daily Mail and Mail on Sunday newspapers.
Controversy flares over informing research subjects about incidental genetic findings | Science
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.